Token Jumps 28% to $9.28 on Institutional Validator Momentum
Injective (INJ) rose 28% to $9.28 as trading volume climbed and Gulf Labs ran an institutional validator, with a staked INJ ETF filing still pending at the SEC.
AI SummaryAI
- INJ rose 28% in 24 hours to $9.28 on Friday, October 16, after an intraday low of $8.50.
- Gulf Labs began operating an institutional validator on Injective per an October 8 announcement.
- Canary Capital filed an amended S-1 in December 2025 for a proposed staked INJ ETF.
- CoinGecko data shows INJ closing near $7.66 on October 14, up from about $6.93 on October 9.
Volume Lifts INJ Out of Its October Range
Injective (INJ) jumped about 28% over the past 24 hours and trades near $9.28 at the time of writing, a sharply stronger session for the token. The move lifted the Injective protocol asset out of the range that capped it through most of October: after dipping to an intraday low of $8.50, buyers pushed the price decisively higher, with roughly 2.29 million INJ changing hands on the day as trading volume expanded in step with the rally. Historical market data from CoinGecko shows the token closing near $7.66 on October 14, itself a recovery from approximately $6.93 on October 9, so the past week has added close to a third to the token's value in four sessions. Daily chart readings back the advance: INJ held above its Ichimoku Cloud, the positive directional indicator stood at 21.51 against 14.75 for its negative counterpart, and the Average Directional Index at 26.25 sat just above the 25 threshold that marks an established trend, though it had cooled from readings above 40 in late September. An earlier COINOTAG reading had the token nearing $8.59 resistance after leading the FDV-to-revenue ranking among major protocols, and the live INJ technical analysis view now frames $9.50 as the next hurdle. The pace is notable as well: daily closes have climbed step by step from $6.93 to $7.66 and now to the $9.28 area, and sustained trade above the old ceiling would mark the first decisive break since the early-October slide. Two institutional threads sit behind the demand, both tied to Injective's effort to connect conventional finance with on-chain infrastructure: a validator partnership in Thailand and a still-pending US fund filing.
Our own support and resistance scoring frames the ground this rally still has to cover: the nearest firm floor sits at $8.2418, scored 87 out of 100, while the strongest overhead barrier stands at $10.3583, scored 66 out of 100. Derivatives positioning looks constructive rather than stretched: perpetual funding reads 0.0071%, and open interest near $40.6 million indicates the move has run mainly on cash demand rather than borrowed leverage. Confirmation would need a funding spike alongside rising open interest, while a close back below $8.2418 would suggest the breakout ran ahead of itself. Momentum this hot also pulls in FOMO-driven entries near local extremes, which makes price behavior at those two levels more telling than the headline percentage.
Gulf Labs Validator and the US Regulatory Pipeline
The Thailand connection is the newest institutional leg. Gulf Labs, a subsidiary of GULF Group, confirmed in an October 8 announcement that it had begun running an institutional validator on the Injective blockchain, taking responsibility for transaction validation, network security and on-chain governance. Its parent operates across energy, telecommunications, banking and cloud infrastructure, with an energy portfolio exceeding 24 gigawatts of installed capacity and telecom businesses serving more than 46 million mobile subscribers. Gulf Labs said the validator work gives it a technical foundation for exploring blockchain applications with local financial institutions, with potential work spanning tokenization, stablecoins, institutional financial services and digital infrastructure in Thailand. Injective's reach is not confined to Southeast Asia: the project's Korea-based team has separately outlined a multi-chain push for USDC payments, evidence that the institutional strategy spans several regions at once. In the United States, Injective Institutional Services secured registration with the SEC as a transfer agent, an affiliation the network applied for in July. The registration lets the unit keep official records of securities ownership, process ownership changes and carry out administrative functions tied to distributions and corporate actions, plumbing that tokenized securities would need. On the fund side, Canary Capital submitted an amended S-1 registration statement to the SEC in December 2025 for a proposed staked INJ exchange-traded fund, built to offer exposure aligned with spot trading in INJ while seeking additional returns through staking. Under the filing, BitGo would act as custodian, while U.S. Bancorp Fund Services would take on administration and cash custody duties; shares would trade on the Cboe BZX Exchange, issued and redeemed in 10,000-share blocks. Canary set up a Delaware trust in June 2025 as an early step toward launching the product, and the proposal remains subject to the regulatory process, with no approval having occurred as of today. On shorter timeframes, four-hour On-Balance Volume climbed to about negative 16.74 million, its best reading in several weeks, while the Commodity Channel Index at 209.77 sits far above the +100 zone, a range that often precedes near-term consolidation. If $9.50 gives way, $10 and then $10.50 come into focus; a pullback would first test the $8.50 to $8.70 band before deeper support near the daily cloud boundary at $7.00.
Primary sources
- CoinGecko · coingecko.com
AI-generated, AI-reviewed, under COINOTAG editorial oversight.

